FI934220L - Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi - Google Patents
Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi Download PDFInfo
- Publication number
- FI934220L FI934220L FI934220A FI934220A FI934220L FI 934220 L FI934220 L FI 934220L FI 934220 A FI934220 A FI 934220A FI 934220 A FI934220 A FI 934220A FI 934220 L FI934220 L FI 934220L
- Authority
- FI
- Finland
- Prior art keywords
- daerav
- vid
- therapy
- framstaellning
- piperidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9211550A FR2696176B1 (fr) | 1992-09-28 | 1992-09-28 | Dérivés de pipéridine, leur préparation et leur application en thérapeutique. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI934220A0 FI934220A0 (fi) | 1993-09-27 |
| FI934220A7 FI934220A7 (fi) | 1994-03-29 |
| FI934220L true FI934220L (fi) | 1994-03-29 |
Family
ID=9433966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI934220A FI934220L (fi) | 1992-09-28 | 1993-09-27 | Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5418241A (fi) |
| EP (1) | EP0591026A1 (fi) |
| JP (1) | JPH06192254A (fi) |
| KR (1) | KR940007022A (fi) |
| CN (1) | CN1087340A (fi) |
| AU (1) | AU659033B2 (fi) |
| CA (1) | CA2107060A1 (fi) |
| CZ (1) | CZ201493A3 (fi) |
| FI (1) | FI934220L (fi) |
| FR (1) | FR2696176B1 (fi) |
| HU (2) | HUT65396A (fi) |
| IL (1) | IL107132A0 (fi) |
| MX (1) | MX9305930A (fi) |
| NO (1) | NO933434L (fi) |
| NZ (1) | NZ248775A (fi) |
| PL (1) | PL172852B1 (fi) |
| SK (1) | SK103293A3 (fi) |
| ZA (1) | ZA937155B (fi) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2731707B1 (fr) * | 1995-03-13 | 1997-04-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| FR2731708B1 (fr) * | 1995-03-13 | 1997-04-30 | Synthelabo | Derives de piperidine, leur procede de preparation et leur application en therapeutique |
| GB9815696D0 (en) * | 1998-07-20 | 1998-09-16 | Pfizer Ltd | Heterocyclics |
| GB9818730D0 (en) * | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collections of compounds |
| WO2000064441A2 (en) * | 1999-04-28 | 2000-11-02 | Respiratorius Ab | Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| CN1355698A (zh) * | 1999-06-15 | 2002-06-26 | 呼吸器有限公司 | 可用作治疗有关支气管收缩的机能障碍的药物的化合物 |
| GB9918425D0 (en) * | 1999-08-04 | 1999-10-06 | Novartis Ag | Organic compounds |
| AU782648B2 (en) * | 1999-11-23 | 2005-08-18 | Janssen Pharmaceutica N.V. | Use of 5HT3 agonists for relaxing the fundus |
| GB0321295D0 (en) * | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines |
| GB0404577D0 (en) * | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
| ES2398975T3 (es) * | 2004-03-01 | 2013-03-25 | Spirogen Sàrl | Derivados de 11-hidroxi-5H-pirrolo[2,1-c][1,4]benzodiazepin-5-ona como intermedios clave para la preparación de pirrolobenzodiazepinas sustituidas en C2 |
| EP1723152B1 (en) * | 2004-03-09 | 2015-02-11 | Spirogen Sàrl | Pyrrolobenzodiazepines |
| ES2338696T3 (es) * | 2005-04-21 | 2010-05-11 | Spirogen Limited | Pirrolobenzodiazepinas. |
| GB0813432D0 (en) * | 2008-07-22 | 2008-08-27 | Spirogen Ltd | Pyrrolobenzodiazepines |
| GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| GB201006340D0 (en) | 2010-04-15 | 2010-06-02 | Spirogen Ltd | Synthesis method and intermediates |
| CN103068405A (zh) | 2010-04-15 | 2013-04-24 | 西雅图基因公司 | 靶向吡咯并苯并二氮杂卓结合物 |
| MX368648B (es) | 2010-04-15 | 2019-10-09 | Seattle Genetics Inc | Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas. |
| US9399641B2 (en) | 2011-09-20 | 2016-07-26 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| CA2850375C (en) | 2011-10-14 | 2019-07-02 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| AU2012322934B2 (en) | 2011-10-14 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepines |
| CA2850264C (en) | 2011-10-14 | 2019-11-05 | Medimmune Limited | Pyrrolobenzodiazepines |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| JP6166728B2 (ja) | 2011-10-14 | 2017-07-19 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | ピロロベンゾジアゼピンの製造に有用な合成方法及び中間体 |
| EP2906249B1 (en) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| DK2906298T3 (en) | 2012-10-12 | 2018-12-17 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| PT2906253T (pt) | 2012-10-12 | 2018-11-05 | Medimmune Ltd | Conjugados de anticorpo anti-psma de pirrolobenzodiazepina |
| EP2906297B1 (en) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| DK2839860T3 (da) | 2012-10-12 | 2019-06-17 | Medimmune Ltd | Pyrrolobenzodiazepiner og konjugater deraf |
| PT2906248T (pt) | 2012-10-12 | 2019-03-04 | Medimmune Ltd | Pirrolobenzodiazepinas e conjugados das mesmas |
| KR101995620B1 (ko) | 2012-10-12 | 2019-07-03 | 에이디씨 테라퓨틱스 에스에이 | 피롤로벤조디아제핀-항체 컨주게이트 |
| BR112015008238A2 (pt) | 2012-10-12 | 2017-11-28 | Adc Therapeutics Sarl | conjugados de pirrolbenzodiazepina-anticorpo anti-cd22 |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US10010624B2 (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| RS61795B1 (sr) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin antitela |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| SMT202200490T1 (it) | 2017-04-18 | 2023-01-13 | Medimmune Ltd | Coniugati di pirrolobenzodiazepina |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| KR102442736B1 (ko) | 2017-06-14 | 2022-09-16 | 에이디씨 테라퓨틱스 에스에이 | 항-cd19 adc의 투여를 위한 투약량 체제 |
| SI3668874T1 (sl) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pirolobenzodiazepinski konjugati |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN113631560B (zh) | 2019-03-15 | 2025-02-18 | 麦迪穆有限责任公司 | 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2579596B1 (fr) * | 1985-03-26 | 1987-11-20 | Inst Nat Sante Rech Med | (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique |
| US5008390A (en) * | 1985-05-23 | 1991-04-16 | Smithkline Beckman Corporation | Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines |
| FR2618435B1 (fr) * | 1987-07-23 | 1989-10-27 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| IT1230703B (it) * | 1989-01-26 | 1991-10-29 | Luso Farmaco Inst | Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono. |
| FR2658823B1 (fr) * | 1990-02-27 | 1992-04-30 | Adir | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . |
| FR2671083B1 (fr) * | 1990-12-31 | 1994-12-23 | Inst Nat Sante Rech Med | Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques. |
| FR2674855B1 (fr) * | 1991-04-03 | 1994-01-14 | Synthelabo | Derives de piperidine, leur preparation et leur application en therapeutique. |
-
1992
- 1992-09-28 FR FR9211550A patent/FR2696176B1/fr not_active Expired - Fee Related
-
1993
- 1993-09-20 EP EP93402280A patent/EP0591026A1/fr not_active Withdrawn
- 1993-09-27 JP JP5239568A patent/JPH06192254A/ja active Pending
- 1993-09-27 NZ NZ248775A patent/NZ248775A/en unknown
- 1993-09-27 US US08/127,058 patent/US5418241A/en not_active Expired - Fee Related
- 1993-09-27 NO NO933434A patent/NO933434L/no unknown
- 1993-09-27 MX MX9305930A patent/MX9305930A/es unknown
- 1993-09-27 CN CN93118081A patent/CN1087340A/zh active Pending
- 1993-09-27 SK SK1032-93A patent/SK103293A3/sk unknown
- 1993-09-27 FI FI934220A patent/FI934220L/fi unknown
- 1993-09-27 HU HU9302726A patent/HUT65396A/hu unknown
- 1993-09-27 ZA ZA937155A patent/ZA937155B/xx unknown
- 1993-09-27 CA CA002107060A patent/CA2107060A1/en not_active Abandoned
- 1993-09-27 PL PL93300514A patent/PL172852B1/pl unknown
- 1993-09-27 KR KR1019930019849A patent/KR940007022A/ko not_active Withdrawn
- 1993-09-27 AU AU48605/93A patent/AU659033B2/en not_active Ceased
- 1993-09-27 CZ CZ932014A patent/CZ201493A3/cs unknown
- 1993-09-27 IL IL107132A patent/IL107132A0/xx unknown
-
1995
- 1995-06-26 HU HU95P/P00434P patent/HU211490A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9302726D0 (en) | 1993-12-28 |
| FI934220A0 (fi) | 1993-09-27 |
| CZ201493A3 (en) | 1994-04-13 |
| CA2107060A1 (en) | 1994-03-29 |
| FI934220A7 (fi) | 1994-03-29 |
| NO933434D0 (no) | 1993-09-27 |
| EP0591026A1 (fr) | 1994-04-06 |
| SK103293A3 (en) | 1994-08-10 |
| HU211490A9 (en) | 1995-11-28 |
| AU4860593A (en) | 1994-04-14 |
| ZA937155B (en) | 1994-05-23 |
| HUT65396A (en) | 1994-06-28 |
| NZ248775A (en) | 1995-02-24 |
| FR2696176A1 (fr) | 1994-04-01 |
| US5418241A (en) | 1995-05-23 |
| MX9305930A (es) | 1994-06-30 |
| CN1087340A (zh) | 1994-06-01 |
| IL107132A0 (en) | 1993-12-28 |
| FR2696176B1 (fr) | 1994-11-10 |
| PL172852B1 (pl) | 1997-12-31 |
| AU659033B2 (en) | 1995-05-04 |
| PL300514A1 (en) | 1994-04-05 |
| JPH06192254A (ja) | 1994-07-12 |
| NO933434L (no) | 1994-03-29 |
| KR940007022A (ko) | 1994-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI934220A0 (fi) | Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi | |
| FI930208L (fi) | Kinazolinderivat | |
| FI935431A7 (fi) | Kiantsoliinijohdannaisia | |
| FI980341L (fi) | 2-oksi-indolijohdannaisia | |
| ATA75293A (de) | Indolderivate | |
| FI933037A7 (fi) | Tiazolylvinylfenylderivat | |
| FI930970A7 (fi) | Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa | |
| FI933756L (fi) | Substituerade tienyl- och pyrrolylkarboxylsyraderivat, framstaellning daerav och laekemedel innehaollande dessa | |
| FI930620A7 (fi) | Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
| FI931880L (fi) | Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel | |
| FI941423A7 (fi) | 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset | |
| FI943727A7 (fi) | Piperidinyylitiasyklisiä johdannaisia | |
| FI945042A7 (fi) | 1-piperatsino-1,2-dihydroindeenijohdannaiset | |
| FI921345L (fi) | Piperidinderivat | |
| FI925924L (fi) | Hydrerat staerkelsehydrolysat med laog kariesframkallande effekt, foerfarande foer framstaellning av detta och tillaempningen av detta hydrolysat | |
| FI922983L (fi) | Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa | |
| FI952722A7 (fi) | Allergian vastaisia triatsolobentsatsepiinijohdannaisia | |
| DE69330497D1 (de) | Chinazolin-derivate | |
| FI925849A7 (fi) | Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar | |
| FI925763L (fi) | Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat | |
| FI20010214A7 (fi) | Asyyliaminoindolijohdannaisia | |
| DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
| FI20002460A7 (fi) | 4-difenyylimetyylipiperidiinijohdannaisia | |
| FI924869L (fi) | Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa | |
| FI923664A7 (fi) | Piperidiinijohdannaisia |